Navigation Links
States in Medical Technology

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... Enforcement Investigations Center, United states Environmental Protection Agency; and Harvey Pass, ... at Karmanos) In response to the United states Environmental Protection Agency's (EPA) ... comprehensive cancer centers in the United states . Caring for nearly 6,000 new patients annually ...

Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder

... form of modafinil, was launched in the United states in June 2009 and is indicated to improve ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ... The company's proprietary products in the United states include: NUVIGIL, TREANDA(R) (bendamustine ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

... Eighteen clinical sites throughout the United states are participating in the study. About ... has been granted orphan drug status in the United states by the FDA, and has received an orphan drug ... the leading organization in the United states devoted to curing and controlling cystic ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... compliance Mayberry points out. "In the United states today, the only class of drugs currently ... many benefits of unit dose packaging. The United states is one of only a few countries in the world where ... effort to the Obama administration and the United states Congress urging public policy that will bring ....

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

... The therapeutic portfolio in the United states includes two marketed products: TREANDA(R) ... for Injection, which is approved in the United states for the treatment of chronic lymphocytic leukemia ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... approximately 1.3 million people in the United states and more than three million people in Europe. ... SIMPONI is approved in Canada and the United states and is available either through the SIMPONI ... exclusive marketing rights outside the United states except in Japan, Indonesia and Taiwan, where ...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... (Nasdaq: UTHR ) announced today that the United states Food and Drug Administration (FDA) has approved ... as we prepare to launch ADCIRCA in the United states at the beginning of August this year," said Roger ... ADCIRCA for pulmonary hypertension in the United states and Puerto Rico from Eli Lilly & Company in ...

New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)

... commonly used by millions of adults in the United states who suffer from acid reflux. ADHD is estimated ... section of the ADDERALL XR product labeling states that coadministration of ADDERALL XR and proton ... VYVANSE, which was introduced in the United states in July 2007 for the treatment of ADHD in ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... approximately 5.3 million people in the United states alone(ii). Every 70 seconds, an American is ... see Lilly's filing with the United states Securities and Exchange Commission. Lilly ... statements. i. USAN (United states Adoptive Name council) adopted, INN ...

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... approximately 200,000 people in the United states and Europe combined, with approximately 30,000 new cases reported per year in each of the United states and Europe. IPF is characterized by ... the regulatory authorities in either the United states or Europe will grant regulatory approval based ...

Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever

... new intravenous analgesic approved in the United states in more than 20 years and the only approved ... for the treatment of pain and fever in the United states and is available in more than 600 combination and ... the exclusive rights to Acetavance in the United states and Canada in 2006 from Bristol-Myers Squibb ...

Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting

... (NDA) is planned for submission to the United states Food and Drug Administration (FDA) this year. The ... and has facilities throughout Europe, the United states and Asia. J&JPRD is leveraging drug discovery ... is a major health care company in the United states dedicated to the needs of primary care providers ...

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

... The dial-in number within the United states is 866-788-0540. The dial-in number for ... 2009. The dial-in number from within the United states is 888-286-8010. For international callers, the ... formed to meet the critical needs of the United states and its allies by developing and commercializing ...

Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier

... in Phase I/II clinical trials in the United states and being developed for the treatment of solid ... Pan HDAC inhibitor product outside of the United states in rapid fashion," said Robert W. Duggan, ... inhibitor product worldwide except for the United states and will pay a royalty to Pharmacyclics on ...

Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder

... in the study traveled eastbound from the United states to France where they were then examined at a ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ... The company's proprietary products in the United states include: AMRIX(R) (cyclobenzaprine hydrochloride ...

FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C

... combination therapy approved in the United states that is not restricted to treatment-naive ... that more than 100,000 patients in the United states failed prior treatment of their hepatitis C virus ... affecting nearly 5 million people in the United states alone. It is the leading cause of cirrhosis and ...

Research Finding Could Revolutionize Asthma Treatment

... of the National Academy of Sciences of the United states of America , a prestigious scientific journal. ... Nearly one in every 13 people in the United states has asthma -- more Americans than have coronary ... is the only national advocacy group in the United states devoted solely to asthma. According to Ms. ...

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

... a class action lawsuit was filed in the United states District Court for the Northern District of ... to the Company's Form 8-K filed with the United states Securities and Exchange Commission filed that ... and individual investors from the United states and around the world. For more information ...

ACRO Comments on NEJM Article on Globalization of Clinical Research

... in this regard. Further, the article states "Investigators in developing countries would ... rate in clinical trials in the United states and Western Europe. According to the non-profit ... 80% of clinical trials in the United states are delayed at least one month because of ...

10-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs

... -- Hospital associations in 10 states have been selected to participate in a program to ... for Healthcare Research and Quality. The states are California, Colorado, Florida, Massachusetts, ... unit-based patient safety program across the 10 states to help prevent infections related to the use of ...

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

... other organs. Roughly 90,000 people in the United states are living with CLL, according to the Leukemia ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

... Campath is indicated in the United states as a single agent for the treatment of B-cell ... first monoclonal antibody approved by the United states Food and Drug Administration (FDA) for the ... Inc., as Campath, and outside the United states as MabCampath(R). For more information ...

Siemens Introduces New Standard of Care for Breast Ultrasound

... (1) 510 (k) pending; not available in the United states (2) Not available in the United states (3) N Engl J Med 356;3. Boyd N.F. et Al., ... Evaluations (5) Not available in the United states (6) Not available in the ...

Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology

... are currently over 160,000 women in the United states living with advanced breast cancer who are ... survival. Over 200,000 women in the United states are diagnosed with breast cancer each year and ... deaths per year due to the disease in the Unites states alone. Bionovo, Inc. Bionovo is a ...

Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated

... -- While 78 percent of mothers in the United states consider influenza a severe and potentially ... "We surveyed mothers throughout the United states to assess their awareness about a family's need ... was conducted via telephone within the United states by CARAVAN Opinion Research Corporation, on ...

Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds

... reduction in the hip fracture rate in the United states if a more active role is taken by all orthopedic ... of the largest research programs in the United states and engage in work designed to improve the health ... Permanente serves 8.7 million members in nine states and the District of Columbia. Today it ...

Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium

... in Phase I trials in adults both in the United states and Spain. Millennium plans to expand the MLN8237 ... Aurora A kinase inhibitor, in the United states -- Lead investigator: Jeffrey R. Infante, ... Phase I trials in adults both in the United states and Japan. New TAK-285 non-clinical data ...

FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A

... the standard of hemophilia care in the United states so that it is now on par with other ... Science Center, and Director of the Mountain states Regional Hemophilia & Thrombosis Center at the ... one in 5,000 males born in the United states has hemophilia. About Bayer HealthCare LLC ...

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)

... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...

Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu

... Centers for Disease Control and Prevention (CDC) states that getting an annual flu vaccine is the single ... and about 36,000 deaths in the United states each year.(3) New Campaign Launches to Educate ... surveys were conducted online within the United states by Harris Interactive on behalf of MedImmune ...

Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen

... The companies also announced that the United states Patent and Trademark Office granted the patent ... honor awarded by the President of the United states for technological innovation. With many ... line at 1-800-905-4369 within the United states or 1-678-999-4572 outside the United States. ...

Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma

... Society, an estimated 66,000 people in the United states will be diagnosed in 2008 with NHL. There ... injection, a product approved in the United states for the treatment of patients with relapsed or ... employs approximately 3,000 people in the United states and Europe. U.S. sites include the company's ...

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)

... Status As previously announced, in the United states the Company continues to work with the COG as ... was granted orphan drug status in the United states in 2001. The NDA was submitted to FDA in October ... than 1,000 new cases diagnosed in the United states each year. A similar incidence of the disease ...

ABC News NIGHTLINE Features HIFU with Sonablate(R) 500 as Non Invasive Treatment Option for Prostate Cancer

... FDA-approved HIFU clinical trials in the United states and abundant clinical data on HIFU outcomes and ... have the ability to travel outside of the United states to receive HIFU, a non invasive, outpatient ... FDA-approved clinical trials in the United states to gather data important for analysis of the ...

Genzyme and Isis Complete Licensing of Mipomersen

... 15,000 apheresis-eligible patients in the United states and Europe. Genzyme and Isis expect to begin ... honor awarded by the President of the United states for technological innovation. With many ... line at 1-800-905-4369 within the United states or 1-678-999-4572 outside the United States. ...

Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study

... is estimated that 27 million adults in the United states have osteoarthritis and the prevalence increases ... system. Cymbalta is approved in the United states for the acute and maintenance treatment of major ... see Lilly's filings with the United states Securities and Exchange Commission. Lilly ...

Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant

... believes should be completed with the majority of states within 30 days. EnviroTru(R) ( ... or so the number of MRSA infections in the United states has increased significantly. At the same time, a ... 18,650 hospital stay-related deaths in the United states in 2005. These figures suggest that MRSA ...

CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model

... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME TO TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

... a supplemental new drug application in the United states later this year to expand the current product ... years of market exclusivity in the United states for relapsed/refractory pediatric ALL. The FDA ... honor awarded by the President of the United states for technological innovation. With many ...

CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate

... THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED states SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED states SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ... REPORTS FILED FROM TIME-TO-TIME WITH THE UNITED states SECURITIES AND EXCHANGE COMMISSION, INCLUDING THE ...
Other Contents
(Date:9/30/2014)... HONG KONG , Sept. 30, 2014 Winners of ... The Economist Events, Innovation Summit scheduled to take place at the ... At the summit, the award winners will share their experiences and ... people who have made a proven innovation over the past decade, ... the night before the summit. It will be the ...
(Date:9/29/2014)... A new study confirms that the exposure to tar ... than of regular cigarettes. Similarly, exposure to nicotine ... increasingly popular type of cigarette in several countries around ... of certain toxic chemicals in the smoke of these ... because lower levels of chemicals in the smoke are ...
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 ... around the globe dropped 52 percent, says the ... Wildlife Fund (WWF). This biodiversity loss occurs disproportionately ... use of high-income countries. , In addition to ... data point to other warning signs about the ...
Breaking Biology News(10 mins):Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7Slim cigarette smokers not exposed to more harmful chemicals 2Half of global wildlife lost, says new WWF report 2
(Date:9/30/2014)... Dennis Thompson HealthDay Reporter ... day, people receive medical implants -- artificial valves, hip ... have been rigorously tested before or after their approval by ... The studies -- conducted by prominent nonprofit groups and ... -- lay the blame for inadequate medical device testing on ...
(Date:9/30/2014)... 30, 2014 Houstonians seeking the latest ... to visit on the Internet. Paul Vitenas, JR. ... respected cosmetic surgeons, has launched a new website to ... of Botox Cosmetic services. The new website ... According to the new website, Botox Cosmetic is a ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Neuromuscular ... people throughout the United States and worldwide. It ... Disease are diagnosed each year, adding to the ... the disease. Approximately 400,000 people in the US ... worldwide. Add to these statistics the 2.4 percent ...
(Date:9/30/2014)... Gummy teeth treatment expert, ... for dark gums. Dark gums are usually considered a ... self-conscious about their smiles. Dr. Farnoosh has pioneered a ... one of the few dental professionals nationwide offering black ... business leaders, high-ranking officials and patients from all over ...
(Date:9/30/2014)... 30, 2014 (HealthDay News) -- Herceptin is the best ... HER2-positive and should remain the standard of care for ... a long-term clinical trial. HER2-positive breast cancers tend ... cancer, according to the Mayo Clinic. For the ... either Herceptin (trastuzumab) or Tykerb (lapatinib) in addition to ...
Breaking Medicine News(10 mins):Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 2Health News:Dr. Paul Vitenas Launches New Website To Showcase The Benefits Of Botox Cosmetic 3Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3Health News:Gummy Smile Dentist, Dr. Alex Farnoosh, is Now Offering Gum Depigmentation for Dark Gums 2
Other TagsOther Tags